| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 唐寅灏 | 中信证券 | 医药生物 | 79.84% | 84.71% | 46.01% | 60.00% | 13 | -8.47% | 2025-07-29 |
| 2 | 刘浩 | 华创证券 | 医药生物 | 79.10% | 68.95% | 51.34% | 20.00% | 2 | -47.33% | 2025-06-12 |
| 3 | 唐寅灏 | 中信证券 | 医药生物 | 78.65% | 84.38% | 51.92% | 60.00% | 13 | -8.47% | 2025-07-18 |
| 4 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 78.51% | 68.80% | 53.71% | 3.45% | 6 | -27.10% | 2025-06-13 |
| 5 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 78.20% | 65.17% | 41.39% | 3.45% | 6 | -27.10% | 2025-06-09 |
| 6 | 唐寅灏 | 中信证券 | 医药生物 | 77.96% | 83.12% | 39.71% | 60.00% | 13 | -8.47% | 2025-07-22 |
| 7 | 刘浩 | 华创证券 | 医药生物 | 77.71% | 74.93% | 34.54% | 20.00% | 2 | -47.33% | 2025-07-23 |
| 8 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 77.15% | 69.63% | 50.04% | 3.45% | 6 | -27.10% | 2025-06-16 |
| 9 | 刘浩 | 华创证券 | 医药生物 | 77.08% | 67.89% | 46.04% | 20.00% | 2 | -47.33% | 2025-06-11 |
| 10 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 77.05% | 66.44% | 37.46% | 3.45% | 6 | -27.10% | 2025-06-10 |
| 11 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 76.82% | 85.80% | 31.17% | 3.45% | 7 | -27.10% | 2025-07-11 |
| 12 | 唐寅灏 | 中信证券 | 医药生物 | 76.29% | 81.06% | 43.08% | 60.00% | 13 | -8.47% | 2025-07-28 |
| 13 | 刘浩 | 华创证券 | 医药生物 | 76.28% | 76.71% | 28.31% | 20.00% | 2 | -47.33% | 2025-07-16 |
| 14 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 76.27% | 64.12% | 45.04% | 3.45% | 6 | -27.10% | 2025-06-11 |
| 15 | 唐寅灏 | 中信证券 | 医药生物 | 75.86% | 81.91% | 42.41% | 60.00% | 13 | -8.47% | 2025-07-23 |
| 16 | 唐寅灏 | 中信证券 | 医药生物 | 75.67% | 81.30% | 49.90% | 60.00% | 13 | -8.47% | 2025-07-17 |
| 17 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 75.32% | 69.91% | 51.51% | 3.45% | 6 | -27.10% | 2025-06-04 |
| 18 | 刘浩 | 华创证券 | 医药生物 | 74.31% | 76.53% | 17.18% | 20.00% | 2 | -47.33% | 2025-07-15 |
| 19 | 刘浩 | 华创证券 | 医药生物 | 74.31% | 72.54% | 32.63% | 20.00% | 2 | -47.33% | 2025-07-25 |
| 20 | 刘浩 | 华创证券 | 医药生物 | 73.38% | 67.64% | 49.54% | 20.00% | 2 | -47.33% | 2025-06-13 |